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Abstract. Italy has been one of themost severely affected countries by the COVID-19 pandemic, and the case fatality
rate (CFR) estimated based on Italian data is one of the highest worldwide. We analyzed public data from the first 50 days
of the epidemic in Italy (from February 24 to April 13, 2020) to evaluate whether evolving testing strategies and capacity
could account for trends in the CFR. The CFR increased during the study period, and a significant positive correlation was
foundbetween theCFRand thepercentageof positive tests amongperformed real-timePCR tests (positive tests% [POS%])
until March 25, suggesting the surveillance system did not detect a growing number of cases in the initial phase of the
epidemic. To avoid distortion due to thedelay between the identification of cases anddeaths, the expectedCFR (expCFR)
was calculated, which represents the ratio between the predicted number of cases and deaths at the end of the epidemic
based on the best fitting logistic curves of the cumulative numbers of cases and deaths. The expCFR began a downward
trend from the 40th day. In the final phase, a decrease in both expCFR and POS% was identified, suggesting an
improvement in surveillance. The results of this study suggest data from the first 50days of theCOVID-19 epidemic in Italy
were severely affected by ascertainment bias. Insufficient testing and isolation of cases could have facilitated the
widespread transmission of COVID-19 in the early stages of the outbreak.
INTRODUCTION
The current COVID-19 pandemic has spread extensively,
causing more than 12 million cases and 566,654 deaths
globally as of July 14, 2020.1 Italy has been one of the most
severely affected countries, with the fourth highest death toll
worldwide. As of July 14, 2020, more than 240,000 cases and
30,000deaths related toCOVID-19 have been identified,2with
important variations among Italian regions and a strong north
to south gradient.3 The most severely affected regions were
those in which the earliest outbreaks occurred, although all
regions recorded cases and deaths due to COVID-19 by the
end of March 2020.3,4 The region of Lombardy, where one of
the two initial outbreaks occurred,5 remains the Italian region
with the highest burden of disease, accounting for 39.1% of
the cumulative number of cases and 49.2% of deaths as of
July 7, 2020.6
A crude case fatality rate (CFR) of 10.6% and 18.3% was
estimated based on data from Italy and Lombardy, re-
spectively,5which ismuchhigher thanwhatwouldbeexpected
according to data from theChinese outbreak (3.6%) or from the
Diamond Princess cruise ship, where robust denominator data
were available as all infections were identified (1%).7,8 Several
hypotheses have been suggested to explain the higher lethality
of COVID-19 in Italy, such as the older age distribution, differ-
ences in thedefinitionof deaths related toCOVID-19compared
with other countries, evolving testing strategies,9 and in the
case of Lombardy, the breakdown of the National Health Ser-
vice due to the dramatic surge in cases.5
The assessment of the CFR of an ongoing outbreak, al-
though critical to guide public health interventions, can be
affected by several biases. Key clinical and epidemiologic
characteristics of the disease are still unknown. Right cen-
soring, caused by the delay between symptom onset and
death between vulnerable and healthy individuals, and
ascertainment bias, due to underreporting of asymptomatic
and mildly symptomatic infections, can, respectively, lead to
under- and overestimations of the CFR.10 In the early stages of
the outbreak, an evaluation of case exportations from Italy be-
tween February 25 and 29, 2020, suggested 27–75% of cases
in the country had not been identified.11 Furthermore, because
of the regional structure of the Italian National Health Service,
testing strategies and laboratory capacity differed greatly
across regions, ultimately leading to inhomogeneous data.5,12
In this study, data from the COVID-19 surveillance were
analyzed to interpret the evolution of the first 50 days of the
epidemic in Italy. We investigated the trend in the CFR and
assessed the correlation between fatality and percentage of
positive tests among performed tests to evaluate whether
evolving testing strategies and capacity could account for
variations in the CFR.
MATERIALS AND METHODS
Study design and data sources. Data collated by the
Italian Civil Protection and made public by the Ministry of
Health were used for this study. The Civil Protection’s online
platform2 has been providing data on the outbreak in Italy
since February 21, 2020, on a daily basis. Reported data in-
clude cumulative counts and daily increases in the number of
performed tests, cases, hospitalized patients, patients hos-
pitalized in intensive care units, and deaths, by Italian region
and province. All data are de-identified and publicly available;
therefore, no patient consent or ethics approval was required
for this study.
For the purpose of this analysis, data from the region of
Lombardy were considered separately from the rest of Italy
because of the dramatic increase in the number of cases in the
region which caused the health system to quickly reach maxi-
mum capacity.13 Data on cases reported from February 24,
2020 until April 13, 2020 were analyzed for the current study.
Definitions and indications for testing. As the outbreak
rapidly spread across Italy, evolving case definitions and in-
dications for testing were issued by the Ministry of Health.
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From February 25, testing was indicated for symptomatic
patients with acute respiratory distress syndrome; severe
acute respiratory infection (SARI); influenza-like illnesswithout
an alternative diagnosis and epidemiologically linked to areas
with secondary transmission of COVID-19; and suspected
cases, that is, patients with acute respiratory infection (ARI)
and with either history of travel to areas reporting community
transmission of COVID-19, close contact with a confirmed
case, or, in the case of healthcare workers, having operated in
an institution with confirmed cases, during the 14 days before
symptom onset.14 On March 9, the definition of suspected
case was updated to include all patients with ARI admitted to
emergency rooms or seeking primary care in areas with evi-
dence of community transmission of COVID-19.15 On April 3,
the followingwere defined as a priority for testing: hospitalized
patients with SARI, patients with ARI in hospitals or nursing
homes, healthcare workers exposed to COVID-19 infection
risk, symptomatic essential workers, patients at risk of de-
veloping severe disease, and first symptomatic individuals in
closed communities.16
Concerning the definition of COVID-19 cases, in the early
stages of the epidemic, for a case to be registered, two pos-
itive real-time PCR (RT-PCR) tests of respiratory specimens
were required, as the diagnostic test performed at regional
reference laboratories had to be confirmed by the National
Institute of Health (Istituto Superiore di Sanità [ISS]).14 From
March 9, 2020, in regions with sustained community trans-
mission, confirmation by the ISS is no longer required.15 In
Italy, all deaths occurring in patients with a positive RT-PCR
test are identifiedasdeaths related toCOVID-19, regardlessof
underlying medical conditions or if the infection was the ulti-
mate cause of death.17
Statistical modeling. A nonnegative logistic function was










The constrain of nonnegativity was necessary to avoid
obtaining negative theoretical values in the first days of the
epidemic. Parameters A, B, C, and D were determined based
on the best fit model of nonlinear regression with the
Levenberg–Marqardt algorithm. To verify the solidity of the
model, a χ2 test was performed on the absolute frequencies of
the theoretical and observed data at 10 equal intervals.
The analysis of the best-fit parameters was interpolated
daily to evaluate the trend as a function of time of the values of
parameter A,which represents the horizontal asymptote of the
function, that is, the predicted number of cases and deaths at
the end of the epidemic. The parameters A, B, C, and D of the
logistic curve were fitted daily, and their value was set each
day according to the best fit models.
Epidemiological parameters. The CFR is traditionally
calculated by dividing the number of deaths in patients who
tested positive for COVID-19 by the cumulative number of
cases at a specific point in time.9 Because of the delay be-
tween a positive test result and death, this measure is an un-
derestimation of disease fatality when the calculation is not
performed ex post.10 To avoid this distortion, we calculated
the expected CFR (expCFR), expressed as the ratio between
the A parameters of the best-fitting logistic curves of the
cumulative number of deaths and cases, which represent the
predicted number of cases and deaths at the end of the epi-
demic, interpolated at a specific point in time. Therefore, the
calculation of the expCFR is not distorted by the time delay
existing between the curves of the cumulative numbers of
cases and deaths, which affects the calculation of the CFR.
The percentage of positive results among performed RT-
PCR tests (POS%) and the number of performed RT-PCR
tests were evaluated to assess the relationship between the
number of cases and testing capacity, and to assess theability
of the Italian health system to respond to the increase in the
number of cases with a proportional increase in the number of
performed tests. We assumed the number of tests performed
at the end of February, when the number of cases in Italy was
limited, to have been sufficient to measure the scale of the
epidemic. To continue to accuratelymonitor the epidemic, the
increase in the number of positive tests (i.e., cases) should
have been mirrored by a proportional increase in percentage
terms in the number of performed tests.
We defined test variation % (TVAR%) as the daily percent-
age variation of the number of performed tests, divided by the













If the value of TVAR% is higher than 100%, the number of
performed tests is increasing faster than POS%, whereas if
the value is lower than 100%, the increase in testing capacity
is not able to follow the increase of POS%.
Correlation between fatality rate and POS%. Scatter-
plots were used to assess the correlation between CFR and
POS%, and expCFR and POS%. Analyses were performed
using MINITAB 19 and MATLAB version R2020a (The Math-
Works, Inc., Natick, MA).
RESULTS
Modeling cases and deaths. The best-fit values for the
parameters of the nonnegative logistic functionsmodeling the
cumulative number of cases and deaths are summarized in
Table 1. Figure 1 shows the cumulative number of cases and
deaths registered in Italy and Lombardy, and the best-fitting
logistic curves. The P-value of the χ2 test performed on the
absolute frequencies of the theoretical and observed data
segmented in 10 equal intervals was < 0.001 for cases and
0.026 for deaths, supporting the validity of the model.
The theoretical peak (i.e., the day on which the second-
order derivative of the cumulative curves calculated consid-
ering the last fitting values takes a value of 0) was reached on
March 27 and 24 for the curve of the cumulative number of
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cases, and March 29 and 28 for the curve of the cumulative
number of deaths, respectively, for Italy and Lombardy. The
actual peak (i.e., the day of maximum daily increase) was
reached on March 21 for the curves of the cumulative
number of cases of both Italy and Lombardy, and March 27
and 21 for the curve of the cumulative number of deaths,
respectively, for Italy and Lombardy. This difference could
be explained by an insufficient number of tests performed
on the days of the actual peaks.
Figure 2 A shows the trend in the values of the parameter A
of the curve of the number of cases in Italy and Lombardy as a
function of the fitting day, from March 19, 2020, when fitting
with a logistic curve became statistically relevant (ratio be-
tween standard error and saturation value of parameter A: 8%
on March 19 versus 51% on March 14), to April 13, 2020. The
value of parameter A systematically increased fromMarch 26,
2020, indicating that the observed number of cases was
higher than expected based on the logistic curve. As shown in
Figure 2B, the percentage variation in the saturation
parameter of the curves of cases and deaths based on Italian
data was synchronized.
Case fatality rate and expCFR. Figure 3 shows the CFR
(from February 24 to April 13) and the expCFR (fromMarch 19
to April 13, due to statistical relevance) in Italy and Lombardy
as a function of time. During the study period, the CFR de-
creased in the first phase, in which the number of cases was
not sufficient for a statistically relevant analysis, and then
systematically increased from2% to 3%onMarch 2 to 12.8%
and 18.1% on April 13, for Italy and Lombardy, respectively.
Conversely, the growth rate of the CFR decreased as a func-
tion of time because of the decreasing effect of the delay
between cases and deaths with the increase in their cumula-
tive numbers. The expCFR reached a plateau and decreased
from April 4. The expCFR calculated on April 13 was 13% for
Italy and 18.5% for Lombardy.
TVAR%. As shown in Figure 4, from the beginning of the
study period until March 24, the daily percentage variation of
POS% was higher than the daily percentage variation of the
TABLE 1
Estimated values and standard errors of the parameters of the best-fitting logistic functions modeling the cumulative number of cases and deaths
as a function of time, based on data from the 2020 COVID-19 outbreak in Italy and Lombardy
Italy Lombardy
Parameter Cases Deaths Cases Deaths
A 170,785 (2,345.72) 22,193.2 (226.73) 62,441 (785) 11,559 (88)
B −2.12 (0.25) −3.4 (0.41) −1.82 (0.19) −3.04 (0.35)
C 7.54 (0.21) 6.63 (0.13) 7.71 (0,24) 6.4 (0.11)
D 77.35 (8.15) 205.94 (17.71) 48.39 (5.27) 180.37 (13.55)
FIGURE 1. Cumulative numberofCOVID-19casesanddeaths registered in Italy andLombardy fromFebruary24 toApril 13, 2020, andbest-fitting
logistic curves. (A) Cases in Italy. (B) Cases in Lombardy. (C) Deaths in Italy. (D) Deaths in Lombardy.
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number of performed tests, resulting in a value of TVAR%
lower than 100%. After March 25, the value of TVAR% was
greater than 100%, indicating that the number of performed
tests increased proportionally more than POS%.
Correlation analysis. The scatterplots depicted in Figures
5 and 6 show the correlation between POS% and fatality, and
results of the analysis are summarized in Table 2. Analyzing
the correlation between POS% and CFR based on data from
Italy and Lombardy (Figure 5A and B, respectively), a similar
trend was found, and three periods were identified in both
plots: 1) data from February 24 to 29, not statistically relevant;
2) data from March 1 to 24, the CFR increased with %POS;
and 3) data from March 25 to April 13, the CFR increased
whereas POS% decreased. Regarding the second cluster of
data, as previously reported, TVAR% was lower than 100%
until March 24; therefore, in this phase, there was a growing
underestimation of positive cases, which led to a growing
overestimation of the CFR. During the third identified period,
although POS% decreased as TVAR was greater than 100%,
the CFR continued to increase. It is hypothesized that this
inconsistency was due to the delay between cases and
deaths, which became critical when the curve of cases
reached its peak before the curve of deaths did. Considering
data from Lombardy, a fourth cluster could be identified: 4)
data from April 10 to 13, both POS% and CFR decreased,
although the result of the correlation analysis was not statis-
tically significant. As the outbreak in Lombardy preceded the
evolution of the epidemic in Italy, the time delay between
cases and deaths could have become negligible in this phase
because of the low influence of the delay on high cumulative
numbers.
To evaluate the correlation between POS% and fatality
without the distortion due to the delay between cases and
deaths, a second analysis was conducted, considering the
correlation between POS% and CFR between February 24
and March 18, and the correlation between POS% and
expCFR between March 19 (when the fitting of the logistic
curves became statistically relevant) and April 14 (Figure 6).
Table 3 summarizes the results of the analysis. The plots
based on data from Italy (Figure 6A) and from the region of
Lombardy (Figure 6B) again showed a similar trend, and four
clusters of data could be identified in both plots: 1) data from
February 24 to 29, not statistically relevant, 2) data fromMarch
1st to 24, fatality increasedwith%POS; 3) data fromMarch 25
to April 3, %POS decreased while expCFR kept increasing,
corresponding to the delay between symptom onset and
death and consistent with the median delay reported by the
ISS18; and 4) data from April 4 to 13, both expCFR and POS%
decreased, albeit with a much less steeper slope than that of
the ascending phase (1).
DISCUSSION
Considering the CFR has a crucial role in informing deci-
sions on the intensity, timing, and duration of public health
interventions,10 and the unprecedented scale and costs of the
mitigation measures implemented in our country,12 it is vital
that CFR estimates are reliable and based on accurate data.
FIGURE 2. Trend in the values andpercentage variation of the parameter A of the best-fitting logistic curvesof the number of COVID-19cases and
deaths in Italy as a function of the fitting day, March 19–April 13, 2020. (A) Trend in the value of parameter A of the curves of the number of cases in
Italy and Lombardy. (B) Percentage variation of parameter A of the curves of the number of cases and deaths, based on Italian data. (C) Percentage
variation of parameter A of the curves of the number of cases and deaths, based on data from Lombardy.
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During the first 50 days of the epidemic in Italy, the crude
CFR showed an increasing trend. A significant positive cor-
relation was found between CFR and POS% until March 25,
when a sufficient daily increase in the number of tests was
achieved. This suggests the surveillance system did not de-
tect a growing number of cases in the initial phase of the ep-
idemic, leading to an increasing underestimation of the CFR.
Conversely, after an initial increasing phase, the expCFR
reached a plateau and began a downward trend from the 40th
day of the epidemic. Furthermore, in the final phase of the
correlation analysis, a decrease in both expCFR and POS%
could be identified, suggesting an improvement in epidemio-
logic surveillance. This trend was not found analyzing the
crude CFR, indicating the methodology we propose for the
calculation of the expCFR could be more accurate, as it is not
distorted by the delay between cases and deaths. The anal-
ysis of the epidemic in the region of Lombardy, where
hospitals endured enormous pressure and reachedmaximum
capacity, showed a similar trend.
According to the results of this study, ascertainment bias
could be a more plausible explanation for the trend in fatality,
rather than a breakdown of the healthcare system. The high
value and increasing trend of the CFR in Italy could be
explained by testing strategies and capacity, which were in-
sufficient to detect the true scale of the outbreak until the 40th
day of the epidemic. Insufficient testing and isolation of cases
could have facilitated the widespread transmission of COVID-
19 in the early stages of the outbreak, both in the community
and in healthcare facilities.
As shown in Table 4, the predicted values of the total
numbers of cases and deaths, interpolated using logistic
curves based on data from the first 50 days of the outbreak,
are lower than the observed numbers of cases and deaths in
Italy as of July 31, 2020. Whereas the logistic curves reached
FIGURE 3. Case fatality rate (CFR) and expected CFR (expCFR) of the 2020 COVID-19 epidemic in Italy and Lombardy as a function of time. (A)
Case fatality ratea as a function of time and expCFRb as a function of time, Italy. (B) Case fatality rate and expCFR as a function of time, Lombardy.
aCase fatality rate is calculatedbydividing thenumberofdeaths inpatientswho testedpositive forCOVID-19by thecumulativenumberof casesat a
specificpoint in time. bExpectedCFR is calculatedbydividing theAparametersof thebest-fitting logistic curvesof the cumulative numberof deaths
and cases, at a specific point in time.
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an expected plateau shortly after the end of our study period,
the actual number of cases and deaths followed a linear
growth for several weeks. This could be due to the important
underestimationof casesanddeaths in the initial phasesof the
epidemic, which may have led to biased results in the longer
term. A severe underestimation, particularly of mild and
asymptomatic cases, was hypothesized analyzing data from
the outbreak in China.19 The uncertainty of the official Chinese
data may have led to inaccurate forecasts by orders of mag-
nitude.19 Phylogenetic analysis suggests that the virus could
have been spreading for weeks before the first cases were
reported in Lombardy, infecting unknown numbers of peo-
ple.20 Furthermore, the percentage of underreported cases in
Italy was estimated to be among the highest worldwide.21 The
number of performed tests progressively improved, as shown
by the value of ΔTEST%. Despite the non-negligible di-
vergence between predictions based on the logistic curves
and the observed data, the difference between the expCFR
calculatedbasedondata from the first 50daysof the epidemic
and the CFR calculated based on observed data from July 31,
2020 is minimal (Italy: expCFR = 13%, CFR = 14.2%; Lom-
bardy: expCFR=18.5%,CFR=17.5%).This studyhadseveral
other limitations. First, the definition of deaths related to
COVID-19 in Italy requires a positiveRT-PCR test, which is not
always performed in patients who are not hospitalized or with
FIGURE 4. Daily percentage variation of positive results among
performed tests (POS%), daily percentage variation of performed
tests, and value of TVAR%, that is, daily percentage variation of
the number of performed tests, divided by the daily percentage
variation of POS%, as function of time, during the 2020 COVID-19
outbreak in Italy.
FIGURE 5. Correlation between the percentage of positive results
amongperformed tests (POS%)and case fatality rate (CFR) during the
2020 COVID-19 outbreak in Italy and Lombardy. (A) Correlation be-
tween POS% and CFRa, based on Italian data. (B) Correlation be-
tween POS% and CFRa, based on data from Lombardy. Black dots:
data from February 24 to February 29. Blue dots: March 1–24. Red
dots: March 25–April 13. Green dots: April 10–13 (only data from
Lombardy). aCase fatality rate is calculated by dividing the number of
deaths in patientswho testedpositive for COVID-19by the cumulative
number of cases at a specific point in time.
FIGURE 6. Correlation between the percentage of positive results
amongperformed tests (POS%) and expected fatality during the 2020
COVID-19 outbreak in Italy and Lombardy. (A) Correlation between
POS%andcase fatality rate (CFR)a fromFebruary 24 toMarch 19, and
between POS%and expected CFR (expCFR)b fromMarch 19 to April
13, basedondata from Italy. (B) Correlation betweenPOS%andCFRa
fromFebruary24 toMarch18, andbetweenPOS%andexpCFRb from
March19andApril 13, basedondata fromLombardy.Blackdots: data
from February 24 to February 29. Blue dots: March 1–24. Green dots:
March 25–April 3. Yellow dots: April 4–13. Red dots: March 21–22,
outlier values for CFR that were excluded from the correlation analysis
of the data fromLombardy. aCase fatality rate is calculated by dividing
the number of deaths in patients who tested positive for COVID-19 by
the cumulative number of cases at a specific point in time. bExpected
CFR is calculated by dividing the A parameters of the best-fitting lo-
gistic curves of the cumulative number of deaths and cases, at a
specific point in time.
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a rapidly evolving disease. Therefore, a certain degree of as-
certainment bias could also affect the numerator of the CFR.
Second, the number of performed tests does not correspond
to the number of tested individuals, as very often the same
individual is tested several times, although not on the same
day. Third, notifications of cases and deaths from individual
regions are often delayed, leading to important fluctuations in
daily increases.
Our results are in linewith those of a previous analysis of the
CFR trend in China and Wuhan, where an upward trend in the
initial phase of the outbreak was also found, and increasing
ascertainment bias was suggested as a plausible explana-
tion.10 The same phenomenon occurred during the SARS
epidemic: different countries reported varying estimates, and
an increasing trend in the crude CFR was identified. This
variation was in retrospect largely explained by difficulties in
standardizing definitions of cases and deaths, and the in-
crease in the CFR over time was most likely an artifact due to
the estimation method. The possibility that the increase in
the CFR could be due to a more lethal mutation of the virus
was suggested during the SARS epidemic, causing mis-
information and panic, and highlighting the detrimental effect
of inconsistent epidemiologic intelligence.22
Since June 15, 2020, Italy has begun progressively de-
escalating social distancing measures. During this transition
phase, accurate estimates of theCFRwill be essential to guide
the evolution of public health measures. Furthermore, con-
sidering no effective vaccine or definitive treatment are avail-
able, prompt testing, rigorous contact tracing, and immediate
isolation of cases are currently the only option to reduce
transmission and prevent a second wave of infections. South
Korea, Singapore, Taiwan, and Hong Kong rapidly imple-
mented widespread testing, aggressive contact tracing, and
isolation, demonstrating the effectiveness of these strategies
without, in the case of South Korea, having to resort to the
extreme social distancingmeasures that were implemented in
Italy.23 Technologically enhanced contact tracing and isolation
of even themildest casesoutside the communitymayalsohave
contributed to the success of these strategies.24
In Italy, until recently the Ministry of Health recommended
testing should be prioritized for symptomatic patients already
suspected of being infected and requiring hospitalization. The
region of Veneto did not apply this stringent policy and used
mass testing in the most affected areas, which included
asymptomatic and mildly symptomatic individuals.5 On April
13, the region of Veneto had tested around 4% of its pop-
ulation, compared with 2% in Lombardy. Applying the same
methodology, we estimated that the expCFR based on data
fromVenetowas6.4%onApril 13, nearly a third of the expCFR
in Lombardy estimated on the same date (18.5%). A recent
modeling study demonstrated that diagnosis campaigns can
decrease both the peak and duration of the epidemic, as
identified cases can be isolated, reducing further trans-
mission.25 Increasing the identification of cases also allows
patients to receive timely clinical care. Results of a study of the
epidemic in Veneto suggest that testing asymptomatic and
mildly symptomatic patients could reduce the proportion of
patients requiring intensive care, which in turn reduces the risk
of reaching maximum intensive care capacity.26
However, resource constraints limit the ability to perform
widespread testing, and it is understandable that in a setting
with limited laboratory capacity or during a surge of infections,
testing should be rationalized. In China, the category of clini-
cally confirmed caseswas introduced for a brief extent of time
in the province of Hubei. Patients were included in this cate-
gory if they have met the clinical criteria and had radiological
evidence of viral pneumonia, regardless of epidemiological
links or laboratory confirmation of infection. The introduction
of this category allowed the timely isolation and treatment of
highly suspected hospitalized cases, whereas testing re-
sources could be reallocated for the identification and iso-
lation of cases in the community.27
TABLE 2
Results of the correlation analysisbetween thepercentageof positive results amongperformed real-timePCR tests andcase fatality rate,* basedon
data from the 2020 COVID-19 outbreak in Italy and Lombardy
Italy Lombardy
Time period Correlation coefficient Average slope (95% CI) Correlation coefficient Average slope (95% CI)
February 24–February 29 −0.78 −0.27 (−0.64; 0.11) −0.46 −0.04 (−0.18; 0.1)
March 1–March 24 0.98† 0.46 (0.42; 0.51) 0.98† 0.38 (0.34; 0.42)
March 25–April 9 −0.92† −0.35 (−0.43; −0.26) −0.87† −0.5 (−0.64; −0.36)
April 10–April 13 (only data from Lombardy) – 0.87 0.17 (−0.26; 0.6)
* Case fatality rate is calculated by dividing the number of deaths in patients who tested positive for COVID-19 by the cumulative number of cases at a specific point in time.
†P < 0.001.
TABLE 3
Resultsof thecorrelationanalysisbetween thepercentageof positive results amongperformed real-timePCRtestsand fatality,* basedondata from
the 2020 COVID-19 outbreak in Italy and Lombardy
Italy Lombardy
Time period Correlation coefficient Average slope (95% CI) Correlation coefficient Average slope (95% CI)
February 24–February 29 −0.78 −0.27 (−0.64; 0.11) −0.46 −0.04 (−0.31; 0.23)
March 1–March 24 0.96† 0.45 (0.38; 0.52) 0.97† 0.39 (0.33; 0.45)
March 25–April 3 −0.94† −1 (−1.37; −0.64) −0.82† −1.19 (−2; −0.37)
April 4–April 13 0.94† 0.11 (0.08; 0.15) 0.95† 0.12 (0.09; 0.16)
*Correlation between POS% and case fatality rate (CFR) from February 24 to March 18, and between POS% and expected CFR (expCFR) from March 19 and April 13. Case fatality rate is
calculated by dividing the number of deaths in patients who tested positive for COVID-19 by the cumulative number of cases at a specific point in time. ExpectedCFR is calculated by dividing the A
parameters of the best-fitting logistic curves of the cumulative number of deaths and cases, at a specific point in time. Data fromMarch 21–22were excluded from the correlation analysis of the data
from Lombardy as these were outliers for the CFR.
†P < 0.001.
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Currently, the gold standard for identifyingCOVID-19 cases
is RT-PCR testing, which is time consuming and requires
certified laboratories and expensive equipment.25 The devel-
opment of accurate and reliable rapid tests that could be
performed at point-of-care and of validated serological tests
to investigate immunity toward COVID-19 will help achieve
effective population-wide surveillance.
In conclusion, results of this study suggest data from the
first 50 days of the COVID-19 epidemic in Italy were severely
affected by ascertainment bias. Resulting epidemiologic pa-
rameters such as theCFRshould therefore be interpretedwith
caution. In the post-lockdown phase, more accurate data will
be essential to inform policy and avoid second waves of in-
fection, which could be achieved by further expanding testing
capacity and broadening case definitions. An important
challenge Italy faced during the COVID-19 outbreak was the
lack of a strong centralized response. The regionalization of
the healthcare system resulted in significant differences in
terms of surveillance strategies, mitigation measures, as well
as in the clinical management of infected patients among
Italian regions, and led to fragmented epidemiological
data.28–30 The severe course of theCOVID-19epidemic in Italy
highlights the urgent need to invest in public health and build
up outbreak preparedness in our country, which would allow
us to provide rapid, effective, and coordinated responses to
future pandemic threats.
Received July 15, 2020. Accepted for publication October 6, 2020.
Published online October 15, 2020.
Acknowledgments: We would like to thank the Italian Ministry of
Health and Civil Protection for divulging the data on the COVID-19
epidemic. Publication charges for this article were waived due to the
ongoing pandemic of COVID-19.
Authors’ addresses: Costanza Vicentini and Carla Maria Zotti, De-
partment of Public Health and Paediatrics, University of Turin, Turin,
Italy, E-mails: costanza.vicentini@unito.it and carla.zotti@unito.it.
StefanoBazzolo,Department of Environment, Landand Infrastructure
Engineering (DIATI), Politecnico of Turin, Turin, Italy, E-mail:
stefano.bazzolo@polito.it. Dario Gamba, School of Medicine, Uni-
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